Identifying abnormalities to guide prognosis and treatment.
A patient-centered, value-based approach to testing.
Leukemias can be highly complex diseases that are a bit like putting together a puzzle. You have to have all the pieces to see the full and complete picture. At Mayo Clinic Laboratories, we offer a spectrum of tests including flow cytometry, chromosomes, FISH, and molecular focused on this disease state. We strive to provide the highest quality services available to complement your clinical practice. We provide accurate results and expert interpretation from a highly focused team of laboratory specialists.
B-cell Lymphoblastic Leukemia Monitoring for Minimal Residual Disease [A Test in Focus]
Min Shi, M.D., Ph.D., a hematologist and co-director of Mayo Clinic's Flow Cytometry Laboratory, explains recent updates to the B-cell lymphoblastic leukemia minimal residual disease flow cytometry assay. This test is used to identify minimal residual disease in patients with a previously confirmed diagnosis of B-cell lymphoblastic leukemia who have completed chemotherapy, immunotherapy or bone marrow transplantation.
Additional Resources
This algorithm can be viewed here.
View this week's case study by Andrew Norgan, M.D., Ph.D., and Audrey Schuetz, M.D., and make your diagnosis.
Useful for obtaining a rapid, expert second opinion on specimens referred by the primary pathologist or obtaining special studies not available locally.
Insights gained from algorithms should be shared with clinicians as a way to improve patient care, increase efficiency, and reduce costs.